Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arbutus Biopharma | ABUS | Nov 22, 2024 | 3.51 | +1.45 |
ARC Document Solutions | ARC | Nov 22, 2024 | 3.39 | 0.00 |
Arcadia Biosciences | RKDA | Nov 22, 2024 | 2.74 | +5.67 |
Arcadium Lithium | ALTM | Nov 22, 2024 | 5.29 | +0.19 |
ArcBest | ARCB | Nov 22, 2024 | 109.91 | +0.83 |
Arcellx | ACLX | Nov 22, 2024 | 90.44 | +3.69 |
Arcelor Mittal ADR | MT | Nov 22, 2024 | 25.11 | -0.71 |
Arch Capital F Pref | ACGLO | Nov 22, 2024 | 22.90 | +0.57 |
Arch Capital G | ACGLN | Nov 22, 2024 | 19.98 | +0.05 |
Arch Capital Group | ACGL | Nov 22, 2024 | 99.69 | +1.12 |
Arch Resources A | ARCH | Nov 22, 2024 | 173.64 | -0.60 |
Archer Aviation A | ACHR | Nov 22, 2024 | 6.04 | +4.50 |
Archer Daniels Midland | ADM | Nov 22, 2024 | 53.13 | -0.11 |
Archrock | AROC | Nov 22, 2024 | 25.86 | +0.47 |
Arcos Dorados | ARCO | Nov 22, 2024 | 8.40 | +0.84 |
Arcosa | ACA | Nov 22, 2024 | 110.58 | +2.07 |
Arcturus Therapeutics | ARCT | Nov 22, 2024 | 16.91 | -0.94 |
Arcus Biosciences | RCUS | Nov 22, 2024 | 14.70 | +2.94 |
Arcutis Biotherapeutics | ARQT | Nov 22, 2024 | 10.14 | -0.98 |
Ardagh Metal Packaging | AMBP | Nov 22, 2024 | 3.73 | +0.54 |
Ardelyx | ARDX | Nov 22, 2024 | 5.31 | +3.71 |
Ardent Health Partners | ARDT | Nov 22, 2024 | 15.83 | +0.19 |
Ardmore Shipping | ASC | Nov 22, 2024 | 11.85 | -0.34 |
Ares Acquisition II | AACT | Nov 22, 2024 | 10.90 | -0.09 |
Ares Capital | ARCC | Nov 22, 2024 | 22.02 | +1.10 |
Ares Commercial Real Estate | ACRE | Nov 22, 2024 | 7.12 | -0.56 |
Ares Dynamic Credit Allocation Fund | ARDC | Nov 22, 2024 | 15.27 | -0.07 |
Ares Management A | ARES | Nov 22, 2024 | 175.52 | +0.29 |
Ares Management Pref B | ARES-B | Nov 22, 2024 | 55.71 | 0.00 |
Argan | AGX | Nov 22, 2024 | 158.63 | +2.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.